Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Hosztafi

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
General and Comparative Endocrinology|April 1, 1989
Effects of precocene analogs on the nematode Caenorhabditis remanei (var. Bangaloreiensis). I. Structure/activity relationsA Fodor, T Tímár, I Kiss, et al.
Life Sciences|January 1, 1989
Effects of oxymorphazone in frogs: long lasting antinociception in vivo, and apparently irreversible binding in vitroS Benyhe, G Hoffmann, E Varga, et al.
Bioorganic & Medicinal Chemistry|February 1, 1997
New nepenthone and thevinone derivativesJ Marton, C Simon, S Hosztafi, et al.
Neurochemical Research|August 26, 1998
Affinity profiles of novel delta-receptor selective benzofuran derivatives of non-peptide opioidsM Spetea, S T Nevin, S Hosztafi, et al.
Current Medicinal Chemistry|November 17, 2004
6-oxo-morphinane oximes: pharmacology, chemistry and analytical applicationA Gergely, K Gyimesi-Forrás, P Horváth, et al.
Neurochemical Research|September 1, 1994
Dihydrocodeinone-hydrazone, dihydrocodeinone-oxime, naloxone-3-OMe-oxime, and clocinnamox fail to irreversibly inhibit opioid kappa receptor bindingQ Ni, H Xu, J S Partilla, et al.
Current Medicinal Chemistry|September 1, 2012
A novel µ-opioid receptor ligand with high in vitro and in vivo agonist efficacyE Lacko, A Varadi, R Rapavi, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
General and Comparative Endocrinology|April 1, 1989
Effects of precocene analogs on the nematode Caenorhabditis remanei (var. Bangaloreiensis). I. Structure/activity relationsA Fodor, T Tímár, I Kiss, et al.
Life Sciences|January 1, 1989
Effects of oxymorphazone in frogs: long lasting antinociception in vivo, and apparently irreversible binding in vitroS Benyhe, G Hoffmann, E Varga, et al.
Bioorganic & Medicinal Chemistry|February 1, 1997
New nepenthone and thevinone derivativesJ Marton, C Simon, S Hosztafi, et al.
Neurochemical Research|August 26, 1998
Affinity profiles of novel delta-receptor selective benzofuran derivatives of non-peptide opioidsM Spetea, S T Nevin, S Hosztafi, et al.
Current Medicinal Chemistry|November 17, 2004
6-oxo-morphinane oximes: pharmacology, chemistry and analytical applicationA Gergely, K Gyimesi-Forrás, P Horváth, et al.
Neurochemical Research|September 1, 1994
Dihydrocodeinone-hydrazone, dihydrocodeinone-oxime, naloxone-3-OMe-oxime, and clocinnamox fail to irreversibly inhibit opioid kappa receptor bindingQ Ni, H Xu, J S Partilla, et al.
Current Medicinal Chemistry|September 1, 2012
A novel µ-opioid receptor ligand with high in vitro and in vivo agonist efficacyE Lacko, A Varadi, R Rapavi, et al.
Pageof 3